NASDAQ:MTAC

MedTech Acquisition Competitors

$9.90
+0.03 (+0.30 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.75
Now: $9.90
$9.90
50-Day Range N/A
52-Week Range
$9.45
Now: $9.90
$11.18
Volume43,306 shs
Average Volume95,031 shs
Market Capitalization$272.25 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

MedTech Acquisition (NASDAQ:MTAC) Vs. AJAX, AJAX, BTWN, CMLF, TPGY, and BOWX

Should you be buying MTAC stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to MedTech Acquisition, including Ajax I (AJAX), Ajax I (AJAX), Bridgetown (BTWN), CM Life Sciences (CMLF), TPG Pace Beneficial Finance (TPGY), and BowX Acquisition (BOWX).

Ajax I (NYSE:AJAX) and MedTech Acquisition (NASDAQ:MTAC) are both small-cap unclassified companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, institutional ownership, risk, dividends and earnings.

Profitability

This table compares Ajax I and MedTech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
MedTech AcquisitionN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations for Ajax I and MedTech Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
MedTech Acquisition0000N/A

Valuation and Earnings

This table compares Ajax I and MedTech Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
MedTech AcquisitionN/AN/AN/AN/AN/A

Ajax I (NYSE:AJAX) and MedTech Acquisition (NASDAQ:MTAC) are both small-cap unclassified companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.

Profitability

This table compares Ajax I and MedTech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
MedTech AcquisitionN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for Ajax I and MedTech Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
MedTech Acquisition0000N/A

Valuation & Earnings

This table compares Ajax I and MedTech Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
MedTech AcquisitionN/AN/AN/AN/AN/A

Bridgetown (NASDAQ:BTWN) and MedTech Acquisition (NASDAQ:MTAC) are both small-cap unclassified companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.

Profitability

This table compares Bridgetown and MedTech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
MedTech AcquisitionN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for Bridgetown and MedTech Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
MedTech Acquisition0000N/A

Valuation & Earnings

This table compares Bridgetown and MedTech Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
MedTech AcquisitionN/AN/AN/AN/AN/A

CM Life Sciences (NASDAQ:CMLF) and MedTech Acquisition (NASDAQ:MTAC) are both small-cap financial services companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.

Profitability

This table compares CM Life Sciences and MedTech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life SciencesN/AN/AN/A
MedTech AcquisitionN/AN/AN/A

Valuation & Earnings

This table compares CM Life Sciences and MedTech Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life SciencesN/AN/AN/AN/AN/A
MedTech AcquisitionN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for CM Life Sciences and MedTech Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences0000N/A
MedTech Acquisition0000N/A

MedTech Acquisition (NASDAQ:MTAC) and TPG Pace Beneficial Finance (NYSE:TPGY) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability.

Profitability

This table compares MedTech Acquisition and TPG Pace Beneficial Finance's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MedTech AcquisitionN/AN/AN/A
TPG Pace Beneficial FinanceN/AN/AN/A

Valuation and Earnings

This table compares MedTech Acquisition and TPG Pace Beneficial Finance's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MedTech AcquisitionN/AN/AN/AN/AN/A
TPG Pace Beneficial FinanceN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for MedTech Acquisition and TPG Pace Beneficial Finance, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MedTech Acquisition0000N/A
TPG Pace Beneficial Finance0000N/A

MedTech Acquisition (NASDAQ:MTAC) and BowX Acquisition (NASDAQ:BOWX) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability.

Profitability

This table compares MedTech Acquisition and BowX Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MedTech AcquisitionN/AN/AN/A
BowX AcquisitionN/AN/AN/A

Valuation and Earnings

This table compares MedTech Acquisition and BowX Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MedTech AcquisitionN/AN/AN/AN/AN/A
BowX AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for MedTech Acquisition and BowX Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MedTech Acquisition0000N/A
BowX Acquisition0000N/A


MedTech Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$10.22+1.1%$914.11 millionN/A0.00News Coverage
Ajax I logo
AJAX
Ajax I
0.0$10.22+1.1%$914.11 millionN/A0.00News Coverage
BTWN
Bridgetown
0.0$11.83+2.4%$879.84 millionN/A0.00
CMLF
CM Life Sciences
0.0$15.00+2.9%$830.16 millionN/A0.00Gap Down
TPGY
TPG Pace Beneficial Finance
0.3$18.10+2.5%$791.88 millionN/A0.00
BOWX
BowX Acquisition
0.0$12.99+1.7%$784.27 millionN/A0.00Gap Up
BOAC
Bluescape Opportunities Acquisition
0.0$10.15+2.1%$770.77 millionN/A0.00High Trading Volume
VYGG
Vy Global Growth
0.0$10.20+0.3%$733.13 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.31+0.1%$683.49 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.41+0.9%$670.14 millionN/A0.00
ACIC
Atlas Crest Investment
0.0$10.21+1.9%$638.13 millionN/A0.00
VSPR
Vesper Healthcare Acquisition
1.7$10.60+2.0%$609.50 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.75+0.6%$609.38 millionN/A0.00
HAAC
Health Assurance Acquisition
0.0$10.70+0.7%$592.51 millionN/A0.00
KVSC
Khosla Ventures Acquisition Co. III
0.0$10.15+0.8%$571.45 millionN/A0.00News Coverage
VAQC
Vector Acquisition Corp II
0.0$9.95+0.1%$570.63 millionN/A0.00News Coverage
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.02+0.0%$563.63 millionN/A0.00News Coverage
CFII
CF Finance Acquisition Corp. II
0.3$8.21+1.2%$522.16 millionN/A0.00Gap Down
MOTV
Motive Capital
0.0$10.04+0.9%$519.57 millionN/A0.00
MAAC
Montes Archimedes Acquisition
0.0$9.83+0.0%$516.78 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.95+0.2%$514.91 millionN/A0.00
DGNU
ArcLight Clean Transition Corp. II Unit
0.0$10.26+1.0%$513 millionN/A0.00
SPNV
Supernova Partners Acquisition
0.0$10.06+0.2%$506.15 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.98+0.1%$502.12 millionN/A0.00High Trading Volume
GMII
Gores Metropoulos II
0.0$10.04+1.0%$502 millionN/A0.00High Trading Volume
News Coverage
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.80+0.1%$501.63 millionN/A0.00
EPHY
Epiphany Technology Acquisition
0.0$9.80+0.3%$500.90 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.3$11.06+0.1%$497.70 millionN/A0.00
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.24+0.5%$472.06 millionN/A0.00
GHVI
Gores Holdings VI
0.0$13.64+1.3%$470.58 millionN/A0.00
NGAC
NextGen Acquisition
0.0$9.99+0.1%$468.28 millionN/A0.00
SPFR
Jaws Spitfire Acquisition
0.0$10.70+0.1%$461.44 millionN/A0.00High Trading Volume
HIGA
H.I.G. Acquisition
0.0$10.01+0.2%$457.84 millionN/A0.00
LUXA
Lux Health Tech Acquisition
0.0$10.42+0.2%$449.36 millionN/A0.00Unusual Options Activity
News Coverage
RMGB
RMG Acquisition Co. II
0.0$10.07+0.5%$434.27 millionN/A0.00
FSRV
FinServ Acquisition
0.0$13.55+8.2%$432.45 millionN/A0.00Gap Up
CAP
Capitol Investment Corp. V
0.0$9.98+0.2%$430.39 millionN/A0.00
MUDS
Mudrick Capital Acquisition Co. II
0.0$10.85+1.5%$428.91 millionN/A0.00High Trading Volume
News Coverage
GFX
Golden Falcon Acquisition
0.0$9.86+0.1%$425.21 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.60+1.5%$413.43 millionN/A0.00High Trading Volume
Gap Up
HOL
Holicity
0.0$10.76+1.0%$403.50 millionN/A0.00Unusual Options Activity
News Coverage
NSTB
Northern Star Investment Corp. II
0.0$10.08+0.6%$403.20 millionN/A0.00
PIAI
Prime Impact Acquisition I
0.0$9.91+0.0%$401.46 millionN/A0.00
TSIA
TS Innovation Acquisitions
0.0$10.62+2.9%$398.25 millionN/A0.00News Coverage
Gap Down
RAAC
Revolution Acceleration Acquisition
0.0$10.29+0.2%$394.45 millionN/A0.00
XPOA
DPCM Capital
0.0$10.01+0.8%$386.64 millionN/A0.00
KVSA
Khosla Ventures Acquisition
0.0$10.45+1.0%$375.16 millionN/A0.00Quiet Period Expiration
IGAC
IG Acquisition
0.0$9.98+0.2%$374.25 millionN/A0.00
PRSR
Prospector Capital
0.0$9.86+0.4%$369.75 millionN/A0.00
GMBT
Queen's Gambit Growth Capital
0.0$9.86+0.1%$369.75 millionN/A0.00
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.